Scaling Up Capacity for COVID-19 Testing in the Philippines

  Four months since the first confirmed case of COVID-19 in the Philippines, the number of cases has risen into the thousands. Testing capacity has expanded rapidly, but testing continues to limit the Philippines response. The Philippines has adopted a “whole of government, whole of society” approach to address this global pandemic, grouped around four […]

Read More…

Lessons from the Covid-19 Pandemic: Importance of Diagnostics in Healthcare

  As the world was preparing to celebrate n December 31, 2019, China began reporting to the World Health Organization (WHO), a cluster of cases of pneumonia of unknown aetiology in Hubei Province. One month later on January 30, 2020, after further outbreaks in 18 other countries, the WHO announced that a novel coronavirus, SARS-CoV-2, […]

Read More…

Biomarker research – an untapped avenue for tackling AMR?

Since the discovery of penicillin by Alexander Fleming nearly a century ago, antibiotics have transformed healthcare. Recollections are waning that seemingly innocuous diseases, such as strep throat, were once fatal. But antibiotics are falling victim to their own success. Today’s widespread use of these wonder drugs – not just in human health but also in […]

Read More…

The WHO essential diagnostic list: a tool for the future.

 Prof Adrian Newland on what the WHO essential diagnostic list mean for the future .  The World Health Organisation’s (WHO) Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE-IVD) was set up in 2017 to develop a list of essential diagnostic tests to complement the essential medicines list that has been available for over 40 […]

Read More…